Although lung cancer is histologically heterogeneous, tumor samples obtained from lung cancer patients show a high level of NF-κB activation in both small cell lung cancer and NSCLC, which is significantly correlated with TNM stage and poor prognosis in these patients. Here, NFKB1 is linked to non-small cell lung carcinoma.